Region: Canada

Buyer and seller can be pleased with the BlackBerry patent sale’s outcome

The Canadian company has secured another three years’ worth of income from an encumbered portfolio, while the buyers can take high-quality assets into new markets

03 February 2022

BlackBerry portfolio sold for $600 million to SPV led by US-based patent market insider

New entity can now begin monetising a horde of around 35,000 assets that is already licensed to many major players in the mobile space

31 January 2022

BlackBerry patent sale approaching the now or never point

After so many delays in finalising the transaction, the pressure is on the Canadian company to get it over the line

27 January 2022

Enforcement-related considerations for patent valuation: the perspective from Canada

The valuation of patent rights is not a straightforward matter. In Canada, the remedies available to patent owners are arguably the most important factor in determining value.

12 January 2022

BlackBerry patent sale almost there but still not over the line

“We are literally down to the last few important items now,” says company CEO John Chen on Q3 earnings call

22 December 2021

It’s a big 48 hours for BlackBerry and the patent market in general

The company is due to release its Q3 financials tomorrow, but it is not known whether the touted sale of a portfolio of well over 30,000 individual assets will also be announced

20 December 2021

Crucial clauses in global IP transactions and the importance of local law advice

In this Q&A, three Gowlings WLG professionals provide practical advice from a local law perspective for IP transactions in three jurisdictions: Canada, China and the United Kingdom.

15 December 2021

Post-assignment validity challenges: limits to the doctrine of assignor estoppel and implications of Minerva

The judgment of the US Supreme Court in Minerva Surgical, Inc v Hologic, Inc regarding the limitations of the doctrine of assignor estoppel sheds light on best practices for transactions and due diligence.

08 December 2021

Assignments show Western Digital is the seller in WiLAN’s latest chip patent acquisition

San Jose company transfers semiconductor rights to an affiliate of the Canadian NPE that's litigating against Micron

17 November 2021

Flexibility crucial to growing appeal of big money drug royalty transactions, says leading deal-maker

In the wake of the firm’s latest $250 million investment, Sagard Healthcare Royalty Partners’ Ali Alagheband gives the inside track on life sciences IP-backed revenue sales

01 November 2021

Unlock unlimited access to all IAM content